We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-1.51%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3B
AUM Growth
-$104M
(-3.3%)
Cap. Flow
-$35.7M
Cap. Flow
% of AUM
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
32.3%
Holding
3,551
New
192
Increased
1,348
Reduced
1,018
Closed
188
Avg Time Held Equity + Options
3.8
years
Top 10 Avg Time Held Equity + Options
2.3
years
Top 20 Avg Time Held Equity + Options
2.6
years
Avg Time Held Equity only
3.8
years
Top 10 Avg Time Held Equity only
2.3
years
Top 20 Avg Time Held Equity only
2.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$38.1M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$12.4M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$5.32M |
| 4 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$4.9M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$4.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares International Select Dividend ETF
IDV
|
+$46.2M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$30.4M |
| 3 |
SPDR Gold Trust
GLD
|
+$19M |
| 4 |
CVB Financial
CVBF
|
+$14.9M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$5.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.33% |
| 2 | Technology | 15.36% |
| 3 | Healthcare | 9.27% |
| 4 | Financials | 6.89% |
| 5 | Consumer Discretionary | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Under Armour Class C
UA
$1.99B
| $498 | ﹤0.01% |
78
| – | – |
2016 Q4
27 quarters
|
|
3102
Recursion Pharmaceuticals
RXRX
$1.86B
| $497 | ﹤0.01% |
65
| – | – |
2023 Q2
1 quarter
|
|
3103
SSR Mining
SSRM
$6.49B
| $492 | ﹤0.01% |
37
+22
| +147% | +$319 |
2023 Q2
1 quarter
|
|
3104
Tredegar Corp
TG
$273M
| $492 | ﹤0.01% |
+91
| New | +$531 |
2023 Q3
0 quarters
|
|
3105
Oruka Therapeutics
ORKA
$4.77B
| $490 | ﹤0.01% |
20
| – | – |
2021 Q3
8 quarters
|
|
3106
Caleres
CAL
$448M
| $489 | ﹤0.01% |
17
| – | – |
2023 Q1
2 quarters
|
|
3107
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $483 | ﹤0.01% |
60
| – | – |
2023 Q1
2 quarters
|
|
|
WKLY
3108
DELISTED
SoFi Weekly Dividend ETF
WKLY
| $480 | ﹤0.01% |
10
| – | – |
2021 Q4
7 quarters
|
|
3109
Ramaco Resources Class B
METCB
$252M
| $477 | ﹤0.01% |
44
| – | – |
2023 Q2
1 quarter
|
|
3110
Gibraltar Industries
ROCK
$1.12B
| $473 | ﹤0.01% |
7
| – | – |
2023 Q2
1 quarter
|
|
3111
Definitive Healthcare
DH
$109M
| $471 | ﹤0.01% |
59
| – | – |
2022 Q4
3 quarters
|
|
3112
Sally Beauty Holdings
SBH
$1.56B
| $469 | ﹤0.01% |
+56
| New | +$595 |
2023 Q3
0 quarters
|
|
3113
Twist Bioscience
TWST
$8.8B
| $466 | ﹤0.01% |
23
-5
| -18% | -$110 |
2021 Q2
9 quarters
|
|
3114
DELISTED
Desktop Metal, Inc.
DM
| $466 | ﹤0.01% |
32
| – | – |
2020 Q4
11 quarters
|
|
3115
S&T Bancorp
STBA
$1.72B
| $460 | ﹤0.01% |
17
-95
| -85% | -$2.74K |
2020 Q3
12 quarters
|
|
3116
Shoals Technologies Group
SHLS
$1.21B
| $456 | ﹤0.01% |
25
| – | – |
2022 Q2
5 quarters
|
|
3117
Customers Bancorp
CUBI
$2.53B
| $448 | ﹤0.01% |
13
-1,000
| -99% | -$36.1K |
2023 Q1
2 quarters
|
|
3118
Phibro Animal Health
PAHC
$1.58B
| $447 | ﹤0.01% |
35
+15
| +75% | +$213 |
2021 Q2
9 quarters
|
|
3119
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.68B
| $445 | ﹤0.01% |
21
-42
| -67% | -$1.01K |
2021 Q2
9 quarters
|
|
3120
Napco Security Technologies
NSSC
$1.27B
| $445 | ﹤0.01% |
20
| – | – |
2022 Q2
5 quarters
|
|
3121
Astronics
ATRO
$2.64B
| $444 | ﹤0.01% |
34
| – | – |
2023 Q1
2 quarters
|
|
3122
DELISTED
Immunogen Inc
IMGN
| $444 | ﹤0.01% |
28
| – | – |
2023 Q1
2 quarters
|
|
3123
Cornerstone Strategic Value Fund
CLM
$1.93B
| $443 | ﹤0.01% |
56
| – | – |
2019 Q2
17 quarters
|
|
3124
Onterris Inc
ONT
$493M
| $439 | ﹤0.01% |
15
| – | – |
2023 Q2
1 quarter
|
|
3125
Evolent Health
EVH
$517M
| $436 | ﹤0.01% |
16
-6
| -27% | -$167 |
2021 Q1
10 quarters
|
|
Similar funds
Parallel Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Parallel Advisors held 3,551 positions worth $3B, down 3.3% from $3.11B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parallel Advisors's Q3 2023 filing shows 192 new, 1,348 increased, 1,018 reduced and 188 closed positions. Its largest new stake was iShares MSCI Intl Quality Factor ETF: 96,005 shares worth $3.23M. The largest sale was iShares International Select Dividend ETF, an estimated $46.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q3 2023 buy was iShares MSCI Intl Quality Factor ETF: 96,005 shares worth $3.23M.
- Parallel Advisors added most to iShares Core S&P Total US Stock Market ETF in Q3 2023, an estimated $38.1M increase.
- Parallel Advisors's biggest Q3 2023 reduction was iShares International Select Dividend ETF, cutting an estimated $46.2M.
- Parallel Advisors fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $244K.
- Parallel Advisors's ten largest holdings make up 32% of its $3B portfolio in Q3 2023.
- Parallel Advisors opened 192 new positions and closed 188 in Q3 2023.
- Parallel Advisors's portfolio value fell 3.3% quarter-over-quarter to $3B.
Based on Parallel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.